000 | 01976 a2200529 4500 | ||
---|---|---|---|
005 | 20250515184307.0 | ||
264 | 0 | _c20091006 | |
008 | 200910s 0 0 eng d | ||
022 | _a1074-2484 | ||
024 | 7 |
_a10.1177/1074248409341879 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aShahzamani, Mehran | |
245 | 0 | 0 |
_aThe effect of angiotensin-converting enzyme inhibitor on hemodynamic instability in patients undergoing cardiopulmonary bypass: results of a dose-comparison study. _h[electronic resource] |
260 |
_bJournal of cardiovascular pharmacology and therapeutics _cSep 2009 |
||
300 |
_a185-91 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAngiotensin-Converting Enzyme Inhibitors _xadministration & dosage |
650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
650 | 0 | 4 |
_aCaptopril _xadministration & dosage |
650 | 0 | 4 |
_aCardiopulmonary Bypass _xadverse effects |
650 | 0 | 4 |
_aCoronary Artery Bypass _xadverse effects |
650 | 0 | 4 | _aCritical Care |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypotension _xchemically induced |
650 | 0 | 4 | _aIntraoperative Period |
650 | 0 | 4 | _aLogistic Models |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 | _aRisk Assessment |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aVasoconstrictor Agents _xadministration & dosage |
700 | 1 | _aYousefi, Zohreh | |
700 | 1 | _aFrootaghe, Azam Noori | |
700 | 1 | _aJafarimehr, Elnaz | |
700 | 1 | _aFroughi, Mahnoosh | |
700 | 1 | _aTofighi, Farhood | |
700 | 1 | _aAzadani, Ali N | |
700 | 1 | _aPourhoseingholi, Mohamad Amin | |
700 | 1 | _aAzadani, Peyman Nejatbakhsh | |
773 | 0 |
_tJournal of cardiovascular pharmacology and therapeutics _gvol. 14 _gno. 3 _gp. 185-91 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1177/1074248409341879 _zAvailable from publisher's website |
999 |
_c19122106 _d19122106 |